VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 49 filers reported holding VOR BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,343,758 | -31.4% | 633,848 | 0.0% | 0.01% | -27.3% |
| Q2 2023 | $1,958,590 | -42.6% | 633,848 | 0.0% | 0.01% | -42.1% |
| Q1 2023 | $3,410,102 | -65.0% | 633,848 | -56.8% | 0.02% | -67.8% |
| Q4 2022 | $9,748,401 | +67.1% | 1,465,925 | 0.0% | 0.06% | +55.3% |
| Q3 2022 | $5,834,000 | +3.1% | 1,465,925 | +28.7% | 0.04% | +18.8% |
| Q2 2022 | $5,660,000 | – | 1,138,768 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |